The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASCO 2018 | Moving forwards with CAR T-cells in myeloma
Noopur Raje
• 1 Jun 2018
CAR T-cells are an exciting therapeutic avenue for multiple myeloma (MM). Here, Noopur Raje, MD, of Massachusetts General Hospital Cancer Center, Boston, MA, discusses exciting future routes for this therapy and gives an expert insight into the key focuses of this research. This video was recorded at the American Society of Oncology (ASCO) 2018 Annual Meeting in Chicago, IL.
